Cervical Cancer Awareness Month serves as a pivotal time for healthcare professionals to understand what technologies can help achieve better patient outcomes.
Preventing Cervical Cancer
You play a vital role in educating patients about the signs and symptoms of cervical cancer. Empowering women to recognize abnormalities and pursue prompt medical attention is crucial, as early detection significantly influences treatment outcomes.1
Human Papillomavirus (HPV) plays a considerable role in awareness, as the majority of cervical cancer cases stem from the virus.2 Recognizing the disease's impact on women's health globally underscores the need for a comprehensive approach to care.
As you know, the cornerstone of cervical cancer prevention lies in HPV vaccination, but each year in the United States, approximately 14,000 new cases of cervical cancer are diagnosed.2
Supporting Cervical Cancer Treatment
We’re here to arm you with solutions that enhance your surgical strategies and techniques for the women who require surgical intervention.
CONMED’s AirSeal® Insufflation System has been frequently credited in the gynecologic space for the procedural benefits it offers surgeons. 3,4
Incorporating insights from fellow healthcare professionals enriches a collective understanding of cervical cancer care and the solutions available to support you.
Interviews with practitioners provide valuable perspectives on patient education, preventive strategies, and the evolving landscape of cervical cancer treatment.
Surgical Innovations for Surgeons Treating Women
From maintaining stable pneumoperitoneum during laparoscopic procedures to facilitating exposure and access to the pelvic cavity, we are committed to innovating for and supporting your procedures.
When your patient is faced with a concern that must be addressed surgically, trust CONMED to enable a safe and efficient procedure. 3,4 Together, we’ll continue working towards a healthier future.
Learn more about CONMED’s dedicated solutions for Gynecologic surgeons HERE.
1 "Cervical Cancer." World Health Organization, 17 Nov. 2023, www.who.int/news-room/fact-sheets/detail/cervical-cancer. Accessed 15 Jan. 2024.
2 "Cervical Cancer." American Association for Cancer Research, www.aacr.org/patients-caregivers/cancer/cervical-cancer/. Accessed 15 Jan. 2024.
3 Sroussi J, Elies A, Rigouzzo A, et al. Low pressure gynecological laparoscopy (7mmHg) with AirSeal® System versus a standard insufflation (15mmHg): A pilot study in 60 patients. J Gynecol Obstet Hum Reprod. 2017;46(2):155-158. doi:10.1016/j.jogoh.2016.09.003
4 Buda A, Di Martino G, Borghese M, et al. Low-Pressure Laparoscopy Using the AirSeal System versus Standard Insufflation in Early-Stage Endometrial Cancer: A Multicenter, Retrospective Study (ARIEL Study). Healthcare (Basel). 2022;10(3):531. Published 2022 Mar 14. doi:10.3390/healthcare10030531
Preventing Cervical Cancer
You play a vital role in educating patients about the signs and symptoms of cervical cancer. Empowering women to recognize abnormalities and pursue prompt medical attention is crucial, as early detection significantly influences treatment outcomes.1
Human Papillomavirus (HPV) plays a considerable role in awareness, as the majority of cervical cancer cases stem from the virus.2 Recognizing the disease's impact on women's health globally underscores the need for a comprehensive approach to care.
As you know, the cornerstone of cervical cancer prevention lies in HPV vaccination, but each year in the United States, approximately 14,000 new cases of cervical cancer are diagnosed.2
“If vaccination programs are effectively implemented, approximately 90 percent of invasive cervical cancer cases worldwide could be prevented, in addition to the majority of precancerous lesions,” said Elmar A. Joura, MD, an Associate Professor of Gynecology at the Medical University of Vienna in Austria.1
Supporting Cervical Cancer Treatment
We’re here to arm you with solutions that enhance your surgical strategies and techniques for the women who require surgical intervention.
CONMED’s AirSeal® Insufflation System has been frequently credited in the gynecologic space for the procedural benefits it offers surgeons. 3,4
Dr. Jordi Ponce, Gynecologic Oncologist practicing in Barcelona, Spain, shares his experience operating with AirSeal®.
“We perform a little over a thousand surgeries a year, of which about 400 are pelvic cancer surgeries. AirSeal® allows us to work at a lower pressure and maintain good cavity exposure. There is no cavity loss during specimen extraction…it really has allowed us to work much better.”
Incorporating insights from fellow healthcare professionals enriches a collective understanding of cervical cancer care and the solutions available to support you.
Interviews with practitioners provide valuable perspectives on patient education, preventive strategies, and the evolving landscape of cervical cancer treatment.
Surgical Innovations for Surgeons Treating Women
From maintaining stable pneumoperitoneum during laparoscopic procedures to facilitating exposure and access to the pelvic cavity, we are committed to innovating for and supporting your procedures.
When your patient is faced with a concern that must be addressed surgically, trust CONMED to enable a safe and efficient procedure. 3,4 Together, we’ll continue working towards a healthier future.
Learn more about CONMED’s dedicated solutions for Gynecologic surgeons HERE.
1 "Cervical Cancer." World Health Organization, 17 Nov. 2023, www.who.int/news-room/fact-sheets/detail/cervical-cancer. Accessed 15 Jan. 2024.
2 "Cervical Cancer." American Association for Cancer Research, www.aacr.org/patients-caregivers/cancer/cervical-cancer/. Accessed 15 Jan. 2024.
3 Sroussi J, Elies A, Rigouzzo A, et al. Low pressure gynecological laparoscopy (7mmHg) with AirSeal® System versus a standard insufflation (15mmHg): A pilot study in 60 patients. J Gynecol Obstet Hum Reprod. 2017;46(2):155-158. doi:10.1016/j.jogoh.2016.09.003
4 Buda A, Di Martino G, Borghese M, et al. Low-Pressure Laparoscopy Using the AirSeal System versus Standard Insufflation in Early-Stage Endometrial Cancer: A Multicenter, Retrospective Study (ARIEL Study). Healthcare (Basel). 2022;10(3):531. Published 2022 Mar 14. doi:10.3390/healthcare10030531